Home » GALDERMA GETS FDA APPROVAL FOR PSORIASIS SPRAY
GALDERMA GETS FDA APPROVAL FOR PSORIASIS SPRAY
The FDA has approved Galderma Laboratories' new drug application for Clobex (clobetasol propionate) Spray for the treatment of moderate-to-severe plaque psoriasis. Clobex Spray is the first clobetasol product available in a non-aerosol spray formulation, the company said.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May